Leah Rosenbaum – Assistant Editor, Healthcare & Science, Forbes
Jeremy Levin – CEO, Ovid Therapeutics; Board of Directors Chair, Biotechnology Innovation Organization (BIO)
Michelle McMurry-Heath – President and CEO, Biotechnology Innovation Organization (BIO)
Register online to watch Part 2.
Gain access to four
COVID-19 conversations
co-produced by:
We made four COVID-19 related sessions open to the public. Watch them now!
All Rights Reserved. Forward ® 2021
EBD Group Inc., 3150 Pio Pico Drive, Suite 201, Carlsbad, CA, 92008
The world according to COVID-19: From crisis to long-term impact
Sara Jane Demy - CEO and Founder, Demy-Colton
Rick Bright - Former Director, Biomedical Advanced Research and Development Authority (BARDA), Transition Team, COVID-19 Advisory Board
Jeremy Abbate, Publisher, Scientific American
Ruxandra Draghia-Akli, Global Head, Johnson & Johnson Global Public Health R&D
Amy Finan, CEO, Sabin Vaccine Institute
Richard Hatchett, CEO, CEPI
Stephen G. Brozak, Managing Partner and President, WBB Securities LLC
Prabhavathi Fernandes,Chair, National Biodefense Science Board
Michael Kurilla, Director of Division of Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health